Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes

Hepatology

Volumn 24, Issue 2, 1996, Pages 367-373

  Tapner, Michael ^a   Liddle, Chris ^a,b,c   Goodwin, Bryan ^b,c   George, Jacob ^a   Farrell, Geoffrey C ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 ISOENZYME; DEXAMETHASONE; HUMAN GROWTH HORMONE; MESSENGER RNA; OXYGENASE; PHENOBARBITAL; RECOMBINANT GAMMA INTERFERON; RIBONUCLEASE; TESTOSTERONE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG HYDROXYLATION; ENZYME ACTIVITY; ENZYME REPRESSION; GENE EXPRESSION; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029785072     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008690406     Document Type: Article

References (48)

1. Renton KW, Knickle LC. Regulation of hepatic cytochrome P450 during infectious disease. Can J Physiol Pharmacol 1990;68:777-781.
2. Morgan ET. Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin. Mol Pharmacol 1989;36:699-707.
3. Ghezzi P, Saccardo B, Villa P, Rossi V, Bianchi M, Dinarello C. Role of interleukin-1 in the depression of liver drug metabolism by endotoxin. Infect Immun 1986;54:837-840.
4. Mannering GJ, Deloria LB. The pharmacology and toxicology of the interferons. Annu Rev Pharmacol Toxicol 1986;26:455-515.
5. Morgan ET, Norman CA. Pretranslational suppression of cytochrome P-450h (IIC11) gene expression in rat liver after administration of interferon inducers. Drug Metab Dispos 1990;18:649-653.
6. Morgan ET. Suppression of P450IIC12 gene expression and elevation of actin messenger ribonucleic acid levels in the livers of female rats after injection of the interferon inducer polyrI.polyrC. Biochem Pharmacol 1991; 42:51-57.
7. Ghezzi P, Saccardo B, Bianchi M. Recombinant tumor necrosis factor depresses cytochrome P450-dependent microsomal drug metabolism in mice. Biochem Biophys Res Commun 1986;136:316-321.
8. Nadin L, Butler AM, Jiang X-M, Farrell GC, Murray M. Down regulation of P450s 2C11 and 3A2 in male rat liver by tumor necrosis factor-α. Gastroenterology 1995;109:198-205, 1995
9. Shedlofsky SI, Swim AT, Robinson JM, Gallicchio VS, Cohen DA, McClain CJ. Interleukin-1 depresses cytochrome P450 levels and activities in mice. Life Sci 1987;40:2331-2336.
10. Wright K, Morgan ET. Regulation of cytochrome P450IIC12 expression by interleukin-1 α, interleukin-6, and dexamethasone. Mol Pharmacol 1991; 39:468-474.
11. Barker CW, Fagan JB, Pasco DS. Interleukin-1β suppresses the induction of P4501A1 and P4501A2 mRNAs in isolated hepatocytes. J Biol Chem 1992;267:8050-8055.
12. Abdel-Razzak Z, Corcos L, Fautrel A, Guillouzo A. Interleukin-1β antagonizes phenobarbital induction of several major cytochromes P450 in adult rat hepatocytes in primary culture. FEBS Lett 1995;366:159-164.
13. Abdel-Razzak Z, Loyer P, Fautrel A, Gautier J-C, Corcos L, Turlin B, Beaune P, et al. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 1993;44:707-715.
14. Chen J-Q, Ström A, Gustafsson J-Å, Morgan ET. Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6. Mol Pharmacol 1995;47:940-947.
15. Thal C, El Kahwaji J, Loeper J, Tinel M, Doostzadeh J, Labbe G, Leclaire J, et al. Administration of high doses of human recombinant interleukin-2 decreases the expression of several cytochromes P-450 in the rat. J Pharmacol Exp Ther 1993;268:515-521.
16. Williams SJ, Farrell GC. Inhibition of antipyrine metabolism by interferon. Br J Clin Pharmacol 1986;22:610-612.
17. Williams SJ, Baird-Lambert JA, Farrell GC. Inhibition of theophylline metabolism by interferon. Lancet 1987;2:939-941.
18. Okuno H, Takasu M, Kano H, Seki T, Shiozaki Y, Inoue K. Depression of drug-metabolizing activity in the human liver by interferon-β. HEPATOLOGY 1993;17:65-69.
19. Israel BC, Blouin RA, McIntyre W, Shedlofsky SI. Effects of interferon-α monotherapy on hepatic drug metabolism in cancer patients. Br J Clin Pharmacol 1993;36:229-235.
20. Craig PI, Tapner M, Farrell GC. Interferon suppresses erythromycin metabolism in rats and human subjects. HEPATOLOGY 1993;17:230-235.
21. Singh G, Renton KW. Interferon-mediated depression of cytochrome P-450-dependent drug metabolism. Mol Pharmacol 1981;20:681-684.
22. Craig PI, Williams SJ, Cantrill E, Farrell GC. Rat but not human interferons suppress hepatic oxidative drug metabolism in rats. Gastroenterology 1989;97:999-1004.
23. Craig PI, Mehta I, Murray M, McDonald D, Astrom A, van der Meide PH, Farrell GC. Interferon down-regulates the male-specific cytochrome P450IIIA2 in rat liver. Mol Pharmacol 1990;38:313-318.
24. Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. HEPATOLOGY 1991;13:364-374.
25. Aggarwal BB, Pocsik E. Cytokines: from clone to clinic. Arch Biochem Biophys 1992;292:335-359.
26. Nebert DW, Friedman RM. Stimulation of aryl hydrocarbon hydroxylase induction in cell cultures by interferon. J Virol 1973;11:193-197.
27. Liddle C, Mode A, Legraverand C, Gustafsson J-Å. Constitutive expression and hormonal regulation of male sexually differentiated cytochromes P450 in primary cultured male rat hepatocytes. Arch Biochem Biophys 1992; 298:159-166.
28. Schuetz EG, Schuetz JD, May B, Guzelian PS. Regulation of cytochrome P-450b/e and P-450p gene expression by growth hormone in adult rat hepatocytes cultured on a reconstituted basement membrane. J Biol Chem 1990;265:1188-1192.
29. Kleinman HK, McGarvey ML, Hassell JR, Star VL, Cannon FB, Laurie GW, Martin GR. Basement membrane complexes with biological activity. Biochemistry 1986;25:312-318.
30. Durnam DM, Palmiter RD. A practical approach for quantitating specific mRNAs by solution hybridisation. Anal Biochem 1983;131:385-393.
31. Lebarca C, Paigen K. A simple, rapid and sensitive DNA assay procedure. Anal Biochem 1980;102:344-352.
32. Gonzalez FJ, Song B-J, Hardwick JP. Pregnenolone 16α-carbonitrile-inducible P450 gene family: gene conversion and differential regulation. Mol Cell Biol 1986;6:2969-2976.
33. Ribeiro V, Lechner MC. Cloning and characterization of a novel 3A1 allelic variant: analysis of CYP3A1 and CYP3A2 sex-hormone-dependent expression reveals that the CYP3A2 gene is regulated by testosterone. Arch Biochem Biophys 1992;293:147-152.
34. Kirita S, Matsubara T. cDNA cloning and characterization of a novel member of steroid-induced cytochrome P450 3A in rats. Arch Biochem Biophys 1993;307:253-258.
35. Komori M, Oda Y. A major glucocorticoid-inducible P450 in rat liver is not P450 3A1. J Biochem 1994;116:114-120.
36. Åstrom A, DePierre JW. Metabolism of 2-acetylaminofluorene by eight different forms of cytochrome P-450 isolated from rat liver. Carcinogenesis 1985;6:113-120.
37. UT-A, in rats with portal bypass. J Clin Invest 1989;83:1211-1216.
38. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4354.
39. Waxman DJ, Ko A, Walsh C. Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P-450 isozymes purified from phenobarbital-induced rat liver. J Biol Chem 1983;258:11937-11947.
40. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin reagent. J Biol Chem 1951;193:265-275.
41. Waxman DJ, Dannan GA, Guengerich FP. Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. Biochemistry 1985;24:4409-4417.
42. Waxman DJ, LeBlanc GA, Morrissey JJ, Staunton J, Lapenson DP. Adult male-specific and neonatally programmed rat hepatic P-450 forms RLM2 and 2a are not dependent on pulsatile growth hormone for expression. J Biol Chem 1988;263:11396-11406.
43. Mode A, Wiersma-Larsson E, Gustafsson J-A. Transcriptional and post-transcriptional regulation of sexually differentiated rat liver cytochrome P-450 by growth hormone. Mol Endocrinol 1989;3:1142-1147.
44. Schuetz EG, Li D, Omiecinski CJ, Muller-Eberhard U, Kleinman HK, Elswick B, Guzelian PS. Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. J Cell Physiol 1988;134: 309-323.
45. Delaporte E, Cribb AE, Renton KE. Modulation of rat hepatic CYP3A1 induction by the interferon inducer polyinosinic acid-polycytidylic acid (polyIC). Drug Metab Dispos 1993;21:520-523.
46. Clark MA, Bing BA, Gottschall PE, Williams JF. Differential effect of cytokines on the phenobarbital or 3-methylcholanthrene induction of P450 mediated monooxygenase activity in cultured rat hepatocytes. Biochem Pharmacol 1995;49:97-104.
47. Donato MT, Herrero E, Gómez-Lechón MJ, Castell JV. Inhibition of monooxygenase activities in human hepatocytes by interferons. Toxicology in Vitro 1993;7:481-485.
48. Cribb AE, Delaporte E, Kim SG, Novak RF, Renton KW. Regulation of cytochrome P-4501A and cytochrome P-4502E in the rat during production of interferon α/β. J Pharmacol Exp Ther 1994;268:487-494.